Insulin Degludec
- Strength
- 100 U/mL
- Form
- Injection, Solution
- Class
- Insulin Analog
Novo Nordisk Pharma, Inc.
Not stocked by us — reference only
insulin degludec
Listed by Novo Nordisk
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Insulin Analog |
| Approval route | BLA — biologic licence |
| NDC code | 0169-2660 |
| FDA application | BLA203314 |
| RxNorm concept | 1670011 |
| Package sizes listed | 2 |
| Marketed since | September 2015 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Novo Nordisk Pharma, Inc.
Not stocked by us — reference only
Novo Nordisk Pharma, Inc.
Not stocked by us — reference only
A-S Medication Solutions
Not stocked by us — reference only
Novo Nordisk Pharma, Inc.
Not stocked by us — reference only
A-S Medication Solutions
Not stocked by us — reference only
insulin degludec
Novo Nordisk
Not stocked by us — reference only
insulin degludec
A-S Medication Solutions
Not stocked by us — reference only
insulin degludec
A-S Medication Solutions
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.